Untitled Document
Express Press Release Distribution
Home Page
Submit Press Release
EPR Nationwide Sites
Browse By Industries
Search Press Releases
About EPR
Help Pages
Contact Us
Disclaimer
Privacy Policy
Terms of Service
 
 
 
 
Accounting
Advertising
Aerospace
Agriculture
Apparel & Fashion
Automotive
Biotech
Chemicals
Computers
Construction
Consumer Services
Defense
Education
Electronics
Energy
Entertainment
Environment
Financial
Food & Beverage
Government
Healthcare
Human Resources
Industrial
International Trade
Internet & Online
Law
Management
Marketing
Media
Non Profit
Pharmaceuticals
Real Estate
Retail
Semiconductors
Small Business
Software
Sports
Telecommunications
Transportation / Logistics
Travel
 

EPR Archived News

Archived News 2010
~ December
~ November
~ October

~ September
~ August
~ July

~ June
~ May
~ April

~ March
~ February

~ January

Archived News 2009
~ December
~ November
~ October
~ September
~ August
~ July

~ June
~ May
~ April
~ March
~ February

~ January

Archived News 2008
~ December
~ November
~ October
~ September
~ August
~ July

~ June
~ May
~ April
~ March
~ February
~ January

Archived News 2007
~ December
~ November
~ October
~ September
~ August

~ July

~ June
~ May
~ April
~ March
~ February
~ January

Archived News 2006
~ December
~ November
~ October
~ September
~ August
~ July

~ June
~ May
~ April
~ March
~ February
~ January

Archived News 2005
~ December
~ November
~ October
~ September
~ August
~ July
~ June
~ May
~ April
~ March
~ February
~ January

Archived News 2004
~ December
~ November
~ October
~ September
~ August
~ July

 

 

 

 

Alpha Synuclein-rPeptide Introduces New proteins

Released on: May 8, 2008, 12:21 am

Press Release Author: Sanjay Bhardwaj

Industry: Biotech

Press Release Summary:
Alpha Synuclein, 1-60
Alpha Synuclein, 1-95
Alpha Synuclein, 61-140
Alpha Synuclein, 96-140


Press Release Body: Alpha Synuclein, 1-60
MW: 6,149 Da
Lyophilized powder. Purity > 95% by SDS-PAGE; A deletion mutant of Alpha-Synuclein
(amino acids 1-60), which contains the N-terminal amphipathic domain.
Alpha-Synuclein is a 14 kD (140 amino acids) acidic presynaptic protein. It is a
major component of Parkinson’s disease aggregates and is implicated in the
pathogenesis of Parkinson’s Disease and related neurodegenerative disorders.
Alpha-Synuclein accumulates in the brains of sporadic Parkinson’s disease patients
as a major component of Lewy bodies, which are intraneuronal cytoplasmic inclusions
characteristic of Parkinson’s disease. Alpha-Synuclein appears to associate with
other proteins that aggregate and is found in amyloid plaques and neuritic tangles
in Alzheimer’s disease.
References:
Conway, K.A. et. al., (2000) Biochemistry, 39: 2552
Jakes, R. et al. 1994, FEBS Letters, 345, 27
Masliah, E. et. al., 2001. Proc. Natl. Acad. Sci., USA, 98, 12245
Ueda, K., et. al. 1993. Proc. Natl. Acad. Sci., USA, 90, 11282
For more info:
http://www.rpeptide.com/products/product_details_112.html
Alpha Synuclein, 1-95
MW: 9,391 Da
Description:
Lyophilized powder. Purity > 95% by SDS-PAGE; A deletion mutant of Alpha-Synuclein
(amino acids 1-95), which contains the N-terminal amphipathic domain and the NAC
region. Alpha-Synuclein is a 14 kD (140 amino acids) acidic presynaptic protein. It
is a major component of Parkinson’s disease aggregates and is implicated in the
pathogenesis of Parkinson’s Disease and related neurodegenerative disorders.
Alpha-Synuclein accumulates in the brains of sporadic Parkinson’s disease patients
as a major component of Lewy bodies, which are intraneuronal cytoplasmic inclusions
characteristic of Parkinson’s disease. Alpha-Synuclein appears to associate with
other proteins that aggregate and is found in amyloid plaques and neuritic tangles
in Alzheimer’s disease.
References:
Conway, K.A. et. al., (2000) Biochemistry, 39: 2552
Jakes, R. et al. 1994, FEBS Letters, 345, 27
Masliah, E. et. al., 2001. Proc. Natl. Acad. Sci., USA, 98, 12245
Ueda, K., et. al. 1993. Proc. Natl. Acad. Sci., USA, 90, 11282
For more info:
http://rpeptide.com/products/product_details_113.html
Alpha-Synuclein, 61-140

MW: 8,460 Da
Description:
Lyophilized powder. Purity > 95% by SDS-PAGE; A deletion mutant of Alpha-synuclein
(amino acids 61-140). Additional amino acid (Met) is attached at the N-terminus.
Alpha-Synuclein is a 14 kD (140 amino acids) acidic presynaptic protein. It is a
major component of Parkinson’s disease aggregates and is implicated in the
pathogenesis of Parkinson’s Disease and related neurodegenerative disorders.
Alpha-Synuclein accumulates in the brains of sporadic Parkinson’s disease patients
as a major component of Lewy bodies, which are intraneuronal cytoplasmic inclusions
characteristic of Parkinson’s disease. Alpha-Synuclein appears to associate with
other proteins that aggregate and is found in amyloid plaques and neuritic tangles
in Alzheimer’s disease.
References:
Park, S. M. et al. (2002) Blood, 100(7) 2506
Park, S. M. et al. (2002) Biochemisty. 41, 4137
Conway, K.A. et. al., (2000) Biochemistry, 39: 2552
Jakes, R. et al. 1994, FEBS Letters, 345, 27
Masliah, E. et. al., 2001. Proc. Natl. Acad. Sci., USA, 98, 12245
Ueda, K., et. al. 1993. Proc. Natl. Acad. Sci., USA, 90, 11282
For more info:
http://rpeptide.com/products/product_details_114.html
Alpha-Synuclein, 96-140

MW: 5,217 Da
Description:
Lyophilized powder. Purity > 95% by SDS-PAGE; A deletion mutant of Alpha-Synuclein
(amino acids 96-140). Additional amino acid (Met) is attached at the N-terminus.
Alpha-Synuclein is a 14 kD (140 amino acids) acidic presynaptic protein. It is a
major component of Parkinson’s disease aggregates and is implicated in the
pathogenesis of Parkinson’s Disease and related neurodegenerative disorders.
Alpha-Synuclein accumulates in the brains of sporadic Parkinson’s disease patients
as a major component of Lewy bodies, which are intraneuronal cytoplasmic inclusions
characteristic of Parkinson’s disease. Alpha-Synuclein appears to associate with
other proteins that aggregate and is found in amyloid plaques and neuritic tangles
in Alzheimer’s disease.
References:
Park, S. M. et al. (2002) Blood, 100(7) 2506
Park, S. M. et al. (2002) Biochemisty. 41, 4137
Conway, K.A. et. al., (2000) Biochemistry, 39: 2552
Jakes, R. et al. 1994, FEBS Letters, 345, 27
Masliah, E. et. al., 2001. Proc. Natl. Acad. Sci., USA, 98, 12245
Ueda, K., et. al. 1993. Proc. Natl. Acad. Sci., USA, 90, 11282
For more info:
http://rpeptide.com/products/product_details_115.html


Web Site: http://www.rpeptide.com

Contact Details: Sanjay Bhardwaj
4241 Mars Hill Road,
Bogart, GA 30622, USA
Tel: 678-753-0747
Fax: 678-753-0746
sanjayb@rpeptide.com
www.rpeptide.com

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •  

     

     

    Untitled Document

     

    Submit Press ReleaseSubmit Press Release

     

    Press Release Reports Distribution Reports

     

    Press Release ForumPress Release Forum

     

    Press Release BlogPress Release Blog

     

     

     

     

     

    About | Submit Press Release | Help | Search | Links | Nationwide / EPR Network

    © 2004-2010 Express-Press-Release.Net. Part of EPR-Network.com. All Rights Reserved. All trade marks and names are owned by their respective owners
    Link to Us / Privacy / Disclaimer / Feedback -- Questions, Suggestions, Comments at E-mail: info@EPR-Network.com
    EPR disclaims any content found in press releases -- full disclaimer can be found here

    Contextually linked in LinkedWords

     

     
    Express Press Release Distribution